The Unaudited Standalone and Consolidated financial results for the quarter ended 30th June 2025 were approved by the Board of Directors at its meeting held today i.e. 08.08.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indokem Ltd's Board approved unaudited financial results for Q1 FY26 on August 8, 2025. Standalone income from operations rose to Rs. 3,632 lakhs vs Rs. 3,204 lakhs in Q1 FY25 (~13% YoY growth). The company swung to a standalone profit of Rs. 33 lakhs (EPS Rs. 0.12) from a loss of Rs. 181 lakhs (EPS Rs. (0.65)) in the same quarter last year. On a consolidated basis, revenue grew to Rs. 4,157 lakhs from Rs. 3,698 lakhs, with PAT of Rs. 70 lakhs vs a loss of Rs. 139 lakhs YoY (consolidated EPS Rs. 0.25 vs Rs. (0.50)). The Board also approved entry into a new line of business and a Strategic Marketing Partnership Agreement, along with the appointment of new Cost, Secretarial auditors and the re-appointment of a Non-Executive Director. The 59th AGM is scheduled for September 25, 2025. Auditors issued an unqualified limited review report with no modifications.
The results indicate a clear turnaround from loss-making to profit-making on both standalone and consolidated basis, with revenue also growing double-digits YoY. Positive for shareholders, though margins remain thin and revenue growth did not reach the 20% mark.